CIK 0001641281 · <br>Emerging growth company
Bolt Biotherapeutics, Inc.
Sign in to watch- Ticker
- BOLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 472804636
- Phone
- 650-665-9295
- Business address
- 900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, 94063
- Former names
- Bolt Therapeutics, Inc.
- 4 Open-market buy Chief Financial Officer bought 11,829 shares at an average $0.95 ($11,241)
- 4 Open-market sale Director sold 148,884 shares at an average $0.87 ($128,993)
- 4 Open-market sale Director sold 1,943 shares at $0.90 ($1,751)
- 4 Open-market sale 10% owner sold 3,400 shares at $0.90 ($3,060)
- 4 Open-market sale Director sold 49,173 shares at an average $0.93 ($45,675)
- 4 Open-market sale 10% owner sold 86,054 shares at an average $0.93 ($79,933)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
Page 7 of 15 · 299 filings